Publications

Peer‑reviewed outputs from the Big-data Pharmacoepidemiology & Evidence Lab

Selected Publications

[ FEATURED ]

Association between human papillomavirus vaccination and serious adverse events

Yoon D, et al.

BMJ, 2021

A nationwide cohort study evaluating the safety of HPV vaccination among adolescent girls.

[ FEATURED ]

Cardiovascular, Neurological, and Immunological Adverse Events and PPSV23

Yoon D¶, Jeon HL¶, et al.

JAMA Network Open, 2024

Risk interval analysis of cardiovascular, neurological, and immune events after PPSV23 in seniors.

[ FEATURED ]

Risk of anaphylaxis after COVID‑19 vaccination: A nationwide analysis

Allergy, 2024

Yoon D¶, et al.

Nationwide self‑controlled case series assessing anaphylaxis risk following COVID‑19 vaccination.

Publication Archive

2026

1. Yoon D, Yun C, Beerman I, Beydoun MA, Launer LJ, Song M. Elevated neutrophil-to-lymphocyte ratio and the incidence of autoimmune diseases: evidence from a large prospective cohort study. Sci Rep. 2026 Jan 6;16(1):667. doi: 10.1038/s41598-025-21188-y. PMID: 41495095; PMCID: PMC12780031. (First author)

2025

1. Yun C, Yoon D, Jung SY, Kim M, Beydoun MA, Launer L, Song M. Immune responses to infection and autoimmune diseases in the UK biobank. J Transl Autoimmun. 2025 Sep 17;11:100315. doi: 10.1016/j.jtauto.2025.100315. PMID: 41079905; PMCID: PMC12508843. (Co‑author)
2. Lee CY¶, Yoon D¶, Ha M, Lee MS, Kim YW, Lee J, Shin JY. Psychological Adverse Events and Associated Safety Profiles of Doxepin: A Pharmacovigilance Study Using VigiBase. J Korean Med Sci. 2025 Oct 20;40(40):e260. doi: 10.3346/jkms.2025.40.e260. PMID: 41120108; PMCID: PMC12540971. (Co‑first author)
3. Ko HY¶, Yoon D¶, Kim JH, Jeong HE, Hong SB, Shin WC, Shin JY. Risk of new‑onset seizures following immunization against COVID‑19: a self‑controlled case‑series study. Epidemiol Health. 2025 May 2:e2025024. doi: 10.4178/epih.e2025024. PMID: 40340265. (Co‑first author)
4. Cho Y¶, Yoon D¶, Khosrow-Khavar F, Song M, Kang EH, Kim JH, Shin JY. Cardiovascular, cancer, and infection risks of Janus kinase inhibitors in rheumatoid arthritis and ulcerative colitis: A nationwide cohort study. J Intern Med. 2025 Jan 27. doi: 10.1111/joim.20064. (Co‑first author)
5. Lee H¶, Yoon D¶, Kim JH, Noh Y, Joo EJ, Han JY, Choe YJ, Shin JY. Association of Influenza Vaccination During Pregnancy with Health Outcomes in Mothers and Children: A Population-Based Cohort Study. Clin Pharmacol Ther. 2025 Jan 23. doi: 10.1002/cpt.3565. (Co‑first author)
6. Ko HY, Bea S, Yoon D, Hong B, Bae JH, Cho YM, Shin JY. Incretin-based drugs and the risk of gallbladder or biliary tract diseases among patients with type 2 diabetes: a nationwide cohort study. Lancet Reg Health West Pac. 2025 Mar 10;56:101242. doi: 10.1016/j.lanwpc.2024.101242. (Co‑author)
7. Kim S, Ko HY, Oh J, Yoon D, Kim JH, Choe YJ, Shin JY; CoVaSC Investigators. Risk of Kawasaki Disease/Multisystem Inflammatory Syndrome Following COVID-19 Vaccination in Korean Children: A Self-Controlled Case Series Study. J Korean Med Sci. 2025 Jan 20;40(3):e10. doi: 10.3346/jkms.2025.40.e10. (Co‑author)

2024

1. Yoon D¶, Jung K¶, Kim JH, Ko HY, Yoon BA, Shin JY; CoVaSC Investigators. Risk for Facial Palsy after COVID-19 Vaccination, South Korea, 2021-2022. Emerg Infect Dis. 2024 Nov;30(11):2313-2322. (Co‑first author)
2. Jung H, Park JY, Yoon D, Kang DY, Jung J, Kim JH, Shin JY. Patient-Reported Adverse Events Among Elderly Patients Receiving Novel Oral COVID-19 Antivirals: A Nationwide Sampled Survey in Korea. J Korean Med Sci. 2024 Oct 28;39(41):e270. (Co‑author)
3. Lee J, Lee H, Yoon D, Choi EY, Woo J, Jo B, Kim S, Shin JY, Jung HA. Lazertinib versus Platinum-Based Chemotherapy with EGFR+ NSCLC after Failing EGFR-TKI: A Real-World External Comparator Study. Cancers (Basel). 2024 Jun 7;16(12):2169. (Co‑author)
4. Ha M¶, Yoon D¶, Lee CY, Lee M, Kim YW, Lee JM, Shin JY. Investigating the safety profiles of exogenous melatonin and associated adverse events: A pharmacovigilance study using WHO-VigiBase. J Pineal Res. 2024 Mar;76(2):e12949. (Co‑first author)
5. Kim JH, Yoon D, Ko HY, Jung K, Sunwoo JS, Shin WC, Byun JI, Shin JY. Risk of encephalitis and meningitis after COVID-19 vaccination in South Korea: a self-controlled case series analysis. BMC Med. 2024 Mar 14;22(1):123. (Co‑author)
6. Kim JH, Yoon D, Lee H, Choe YJ, Shin JY. Neurological and immunological adverse events after pneumococcal conjugate vaccine in children using national immunization programme registry data. Int J Epidemiol. 2024 Feb 1;53(1):dyae010. (Co‑author)
7. Bea S¶, Yoon D¶, Jeong HE, Jung J, Park SM, Jeon J, Ye YM, Lee JH, Shin JY. Evaluation of the Regulatory Required Post-Authorization Safety Study for Propacetamol: Nested Case-Control and Case-Time-Control Studies. Yonsei Med J. 2024 Feb;65(2):120-128. (Co‑first author)
8. Yoon D¶, Jeon HL¶, Kim JH, Lee H, Shin JY. Cardiovascular, Neurological, and Immunological Adverse Events and the 23-Valent Pneumococcal Polysaccharide Vaccine. JAMA Netw Open. 2024 Jan 2;7(1):e2352597. (Co‑first author)
9. Yoon D¶, Kim JH¶, Jeong HE, Ko HY, Kim SR, Shin JY; CoVaSC Investigators. Risk of anaphylaxis after COVID-19 vaccination in South Korea: A nationwide self-controlled case series analysis. Allergy. 2024 Mar;79(3):754-757. (Co‑first author)
10. Yoon D, Jeong HE, Choi S, Shin JY, Bang SM. Dynamic Patterns and Persistence of Anticoagulation Therapy in Patients with Venous Thromboembolism in South Korea: A Nationwide Cohort Study. Thromb Haemost. 2024 Feb;124(2):152-162. (First author; Editor’s Choice)

2023

1. Yoon D¶, Jeong HE¶, Choi S, Lee D, Shin JY, Bang SM. Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with VTE: A nationwide cohort study. Cancer Med. 2023 Nov;12(21):20538-20543. (Co‑first author)
2. Yoon D, Jeong HE, Park S, You SC, Bang SM, Shin JY. Real-world data emulating randomized controlled trials of non-vitamin K antagonist oral anticoagulants in patients with venous thromboembolism. BMC Med. 2023 Sep 29;21(1):375. (First author)
3. Kim JH, Yoon D, Noh Y, Jung J, Choe YJ, Shin JY. Predictors of COVID-19 Vaccine Hesitancy Among Parents of Children Aged 5-11 Years in Korea. J Korean Med Sci. 2023 Oct 30;38(42):e315. (Co‑author)
4. Noh Y, Ko HY, Kim JH, Yoon D, Choe YJ, Choe SA, Jung J, Shin JY. Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events. Epidemiol Health. 2023;45:e2023054. (Co‑author)
5. Yoon D¶, Jeon HL¶, Noh Y, Choe YJ, Choe SA, Jung J, Shin JY. A nationwide survey of mRNA COVID-19 vaccinee’s experiences on adverse events and its associated factors. J Korean Med Sci. 2023 Jun 05;38(22):e170. (Co‑first author)
6. Moon HJ, Lee H, Yoon D, Koo YS, Shin JY, Lee SY. Premature Mortality and Causes of Death Among People With Epilepsy: A Nationwide Population-Based Incident Cohort Study. Neurology. 2023 May 16;100(20):e2060-e2070. (Co‑author)

2022

1. Jeong HE, Bea S, Yoon D, Jung J, Park SM, Jeon J, Ye YM, Lee JH, Shin JY. A study of the regional differences in propacetamol-related adverse events using VigiBase data. Sci Rep. 2022 Dec 13;12(1):21568. (Co‑author)
2. Yoon D¶, Song I¶, Jeon HL, Bea S, Choi A, Lee H, Shin JY. Clinical and cost-saving effects of the DUR modernization project in inpatient and outpatient settings in Korea. J Patient Saf. 2022 Sep 1;18(6):605-610. (Co‑first author)
3. Noh Y, Kim JH, Yoon D, Choe YJ, Choe SA, Jung J, Lee SW, Shin JY. Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea. Epidemiol Health. 2022;44:e2022061. (Co‑author)

2021

1. Yoon D¶, Kim J¶, Shin J. Differential Demographic and Clinical Characteristics between MMR Vaccinated and Unvaccinated Children. Vaccines (Basel). 2021 Jun 15;9(6):653. (Co‑first author)
2. Yoon D, Lee JH, Lee H, Shin JY. Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls. BMJ. 2021 Jan 29;372:m4931. (First author)
3. Park HH, Kim JH, Yoon D, Lee H, Shin JY. Gender differences in the adverse events associated with cardiovascular drugs. Int J Clin Pharm. 2021 Aug;43(4):1036-1044. (Co‑author)
4. Yoon D, Lee H, Baek YH, Jeong HE, Shin JY. Prevalence and Its Correlation with Sustained Opioid Use in Korea: A Group-Based Trajectory Analysis. J Psychoactive Drugs. 2021;53(3):224-229. (First author)

2020

1. Jeon HL, Lee H, Yoon D, Lee Y, Kim JH, Jee D, Shin JY. Burden of diabetic macular oedema in patients receiving antivascular endothelial growth factor therapy in South Korea. BMJ Open. 2020 Dec 29;10(12):e042484. (Co‑author)
2. Choi J¶, Yoon D¶, Park M, Joung KI, Shin JY. Topiramate-related adverse events: Pattern and signals in the KAERS, 2010-2017. Medicine (Baltimore). 2020 Oct 16;99(42):e22669. (Co‑first author)
3. Yoon D, Kim JH, Lee H, Shin JY. Updates on Vaccine Safety and Post-Licensure Surveillance for AEFI in South Korea, 2005-2017. Yonsei Med J. 2020 Jul;61(7):623-630. (First author)

2019

1. Kim D, Song I, Yoon D, Shin JY. Pediatric codeine prescriptions in outpatient and inpatient settings in Korea. Am J Manag Care. 2019 Aug 1;25(8):e224-e229. (Co‑author)

2018

1. Yoon D, Song I, Noh Y, Li J, Shin JY. Consistency of listed indications and contraindications between the U.S., the U.K., Japan, and Korea. Regul Toxicol Pharmacol. 2018 Oct;98:168-170. (First author)
2. Noh Y, Yoon D, Song I, Jeong HE, Bae JH, Shin JY. Discrepancies in the Recommendations of Pregnancy Information in Prescription Drug Labeling. J Womens Health. 2018;27(9):1086-1092. (Co‑author)

KCI-indexed Journals

1. Lee JY, Oh JI, Yoon D, et al. Analysis of Advanced Regenerative Medicine Literature. J Korean Acad Soc Manag Care Pharm. 2022;11(2):98-103. (Co‑author)
2. Kim B, Yoon D, Shin JY. Trends in Adverse Event Reports and Signal Detection of AE Following Vaccination. Yakhak Hoeji 2021;65(5):355-362. (Co‑author)
3. Bea S, et al. Exploring the Perception on DUR System and Modernization Pilot Project. Korean J Clin Pharm 2021;31(2):104-114. (Co‑author)
4. Song JW, et al. Arthralgia and myalgia associated with the use of bisphosphonate. Korean J Clin Pharm 2021;31(3):180-187. (Co‑author)
5. Noh Y¶, Yoon D¶, Shin JY. Impact of an Infliximab Biosimilar on Utilization of TNF-α inhibitors in South Korea. Yakhak Hoeji 2020;64(1):39-46. (Co‑first author)
6. Lee JE, et al. Current status and examples of patient registries and proposal of planning in Korea. Yakhak Hoeji 2020;64(5):358-368. (Co‑author)
7. Bae JH, et al. Establishment of Framework for the Development of Drugs Based on RWD/RWE. JPERM 2019;11:62-71. (Co‑author)
8. Kim HJ, et al. Selecting the priority research topics addressing unmet postimmunization safety needs. Korean J Clin Pharm 2019;29(3):173-185. (Co‑author)

Interested in collaborating or supporting our research?

We welcome partnership opportunities with academic institutions and industry leaders to advance healthcare data evidence and pharmacoepidemiology research.